Updated information: b5 d section - serial and lot #, expiration date, explant date, manufacture date 03/30/2016 patient height 4'8 ft.Associated medwatches: 2916714-2020-00191, 2916714-2020-00194.Visual inspection: we have checked for possible damages, deformations of the housing or other abnormalities.The following observations were made during the visual inspection: deposits in the outlet spout.Permeability test: this test is carried out with the product in the horizontal position with a hydrostatic pressure difference of approx.30 cmh2o in the direction of flow.The test showed that the progav 2.0 is permeable.Adjustability test: thus indicating whether the valve is fully adjustable within the full range of specified pressure settings (in increments of 5 cmh2o).The progav 2.0 was found to be adjustable to all pressure settings.Braking force and brake function test a specific measurement device apparatus of braking force is used to investigate the braking force and the brake function of adjustable valves.This apparatus tests whether the braking function is present and how much force must be exerted on the housing to release the rotor to adjust the valve using the integrated magnet of the braking force apparatus.The braking force of the progav 2.0 was within the specified tolerance and the brake function operated as expected.After dismantling of the valve, slightly deposits were found in progav 2.0.Based on our investigation, we are not able to substantiate the claim of "programming issues".At the time of the investigation, it is not clear to us how the mentioned functional impairment occurred.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of non-visible deposits might compromise the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
|